AlphaYou
Overview
No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.
Key stats
Aug 16- Open
- $111.49
- 52-wk high
- $134.38
- High
- $111.97
- 52-wk low
- $81.39
- Low
- $110.79
- Prev close
- $111.25
Smart money
Earnings
Reported Jul 16, 2026
Earnings came in 2.3% above what analysts expected.
Financials
Jun 2025 to Mar 2026
What it sold, what it cost, what was left.
Jun 2025Sep 2025Dec 2025Mar 2026
| USD | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|
| What came in | ||||
| RevenueTotal revenue | $11.14B | $11.37B | $11.46B | $11.16B |
| Cost of what it soldCost of revenue | $4.85B | $5.03B | $4.92B | $4.88B |
| Gross profit | $6.29B | $6.34B | $6.54B | $6.28B |
| What it spent | ||||
| Research and development | $732.0M | $785.0M | $735.0M | $756.0M |
| Sales and adminSelling, general and administrative | $3.09B | $3.05B | $3.13B | $3.74B |
| Other operating costsOperating costs not itemised in the filing's summary | $414.0M | $472.0M | $422.0M | -$55.0M |
| Total operating expenses | $4.24B | $4.31B | $4.29B | $4.44B |
| What was left | ||||
| Operating profitOperating income | $2.05B | $2.06B | $2.25B | $1.84B |
| Interest on debtInterest expense | $121.0M | $44.0M | $120.0M | $174.0M |
| Profit before tax | $2.15B | $2.18B | $2.36B | $1.45B |
| TaxIncome tax expense | $371.0M | $536.0M | $582.0M | $372.0M |
| Net profitNet income | $1.78B | $1.64B | $1.78B | $1.08B |
| EBITDAEarnings before interest, tax, depreciation, amortisation | $3.05B | $3.09B | $2.82B | $2.25B |
Technicals
Technicals
Price structure
This stock is in a strong uptrend, and looks overbought after a fast run-up.
Trend
Strong uptrend
85 / 100
RSI 14
72overbought
20D volatility
21%annualized
52-week range
$111.25$81.39$134.38
20D support
News
News
What the news says
50 articles · 7 days
Coverage is bullish
27 bullish · 21 neutral · 2 bearish
Tone of tracked coverage
Thompson Investment Management Inc. Has $1.28 Million Stock Position in Abbott Laboratories $ABT
BullishAug 14Clark & Stuart Inc Has $3.12 Million Position in Abbott Laboratories $ABT
Leans bullishAug 14Top Abbott Executive Makes Bold Move With Fresh Insider Stock Sale
Leans bearish
